Speaker Profile
M.D., CMO & Co-Founder, Kali Tx
Biography
As a seasoned drug developer and leader, Min brings 25+ years of industry experience across multiple therapeutic areas, from pre-IND and phase 1-4 studies. During her 22-year tenure at Genentech/Roche from drug discovery to late-stage of global development with therapies of anti-VEGF, anti-CD20, anti-IL-6R, BTK inhibitor (etc), her significant contributions and clinical leadership, including her last role as Global Development Lead, resulted in global approvals in multiple autoimmune diseases and severe COVID-19. Prior to Kali, she took several Senior leadership roles in biotech, including SVP & Head of Clinical Development, ClinPharm, Toxicology and Pharmacovigilance at AnaptysBio, SVP & Head of Clinical Development at Alpine Immune Sciences (acquired by Vertex Pharmaceuticals) and Head of Autoimmune Franchise at Annexon Biosciences. Min was trained as a neurologist, received her MD from Suzhou Medical College and Master of Science in Immunology from the University of Calgary.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
